Use of 90-Day Mortality More Appropriate For TAVR/SAVR Performance Evaluation
A study of TAVR and SAVR admissions over a 4-year period revealed 30-day mortality rates may be misrepresenting outcomes at 1 year.
Related Articles
Harnessing Patient Insights: The Role of PROs in Managing Psoriasis and Psoriatic Arthritis
This feature highlights the views of 3 experts on the integration of patient-reported outcomes into the management of psoriatic disease.
SimulatED™: Personalizing Treatment Choices to Achieve Glycemic and Weight Management Goals
Juan Pablo Frias, M.D.; Jessica Hansen, MD
Harnessing Patient Insights: The Role of PROs in Managing Psoriasis and Psoriatic Arthritis
This feature highlights the views of 3 experts on the integration of patient-reported outcomes into the management of psoriatic disease.
Alvin Wells, MD, PhD: Testing and Monitoring Rheumatic Disease With the Ps Mnemonic
Wells discussed the importance and recommended frequency for several factors, including lipid panels, chest X-rays, pregnancy tests, and flu vaccines.
Study Finds Traditional Risk Scores Miss Most Patients at Risk of First Heart Attack
New study finds ASCVD risk score often misses at-risk patients for first acute coronary syndrome, highlighting need for better prediction methods.
Anemia Impacts Dependence in Daily Activities of Living for Older Women
An investigation into basic and instrumental activities of daily living in older female patients found greater reliance in those with anemia.
US Veterans Have Higher Prevalence of Skin Cancer, Psoriasis Versus Non-Veterans
These findings further endorse the need for health care quality improvements for veterans, given the rates of melanoma, skin cancer, and psoriasis.
Harnessing Patient Insights: The Role of PROs in Managing Psoriasis and Psoriatic Arthritis
This feature highlights the views of 3 experts on the integration of patient-reported outcomes into the management of psoriatic disease.
Study Finds Traditional Risk Scores Miss Most Patients at Risk of First Heart Attack
New study finds ASCVD risk score often misses at-risk patients for first acute coronary syndrome, highlighting need for better prediction methods.
Focus on Pathways: Understanding and Treating Menopause
HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care…